Mylan Says Fed. Circ. Jurisdiction Rule Unfair To Generic Cos.
Mylan urged the Federal Circuit on Monday to rethink a decision that found it must face patent infringement suits over two planned generic drugs in the District of Delaware because the...To view the full article, register now.
Already a subscriber? Click here to view full article